| Title | The Relationship of Duffy Gene Polymorphism, High Sensitivity C-Reactive Protein, and Long-term Outcomes. |
| Publication Type | Journal Article |
| Year of Publication | 2023 |
| Authors | Ha ET, Taylor KD, Raffield LM, Briggs M, Yee A, Elemento O, Parikh M, Peterson SJ, Frishman W, Gerszten RE, Wilson JG, Kelsey K, Tahir UA, Reiner A, Auer P, Seeman T, Rich SS, Carson AP, Post WS, Rotter JI, Aronow WS |
| Journal | medRxiv |
| Date Published | 2023 Aug 08 |
| Abstract | BACKGROUND: Black adults have higher incidence of all-cause death and worse cardiovascular outcomes when compared to other populations. The Duffy chemokine receptor is not expressed in a large majority of Black adults and the clinical implications of this are unclear. METHODS: Here, we investigated the relationship of Duffy receptor status, high-sensitivity C-reactive protein (hs-CRP), and long-term cardiovascular outcomes in Black members of two contemporary, longitudinal cohort studies (the Jackson Heart Study and Multi-Ethnic Study of Atherosclerosis). Data on 4,307 Black participants (2,942 Duffy null and 1,365 Duffy receptor positive, as defined using Single Nucleotide Polymorphism (SNP) rs2814778) were included in this analysis. RESULTS: Duffy null was not independently associated with elevated levels of serum hs-CRP levels once conditioning for known locus alleles in linkage disequilibrium with the Duffy gene. Duffy null status was not found to be independently associated with higher incidence of all-cause mortality or secondary outcomes after adjusting for possible confounders in Black participants. CONCLUSIONS: These findings suggest that increased levels of hs-CRP found in Duffy null individuals is due to co-inheritance of CRP alleles known to influence circulating levels hs-CRP and that Duffy null status was not associated with worse adverse outcomes over the follow-up period in this cohort of well-balanced Black participants. |
| DOI | 10.1101/2023.08.03.23293626 |
| Alternate Journal | medRxiv |
| PubMed ID | 37609271 |
| PubMed Central ID | PMC10441500 |
| Grant List | R01 HL105756 / HL / NHLBI NIH HHS / United States |
